Bayesian Capital Management’s MaxLinear MXL Stock Holding History

Bayesian Capital Management’s Portfolio MXL Stock Details MXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-45,143	Closed	-$893K	–	845
2024 Q4	$893K	Buy	+45,143	New	+$724K	0.11%	249
2024 Q3	–	Sell	-21,690	Closed	-$437K	–	926
2024 Q2	$437K	Sell	21,690 -7,200	-25%	-$142K	0.05%	412
2024 Q1	$539K	Buy	+28,890	New	+$577K	0.05%	419
2022 Q3	–	Sell	-21,620	Closed	-$735K	–	915
2022 Q2	$735K	Buy	+21,620	New	+$906K	0.14%	232
2017 Q1	–	Sell	-11,492	Closed	-$251K	–	609
2016 Q4	$251K	Buy	+11,492	New	+$238K	0.06%	466
2016 Q3	–	Sell	-11,625	Closed	-$209K	–	454
2016 Q2	$209K	Buy	+11,625	New	+$216K	0.13%	325
2016 Q1	–	Sell	-13,225	Closed	-$195K	–	412
2015 Q4	$195K	Buy	+13,225	New	+$199K	0.28%	184

Other funds holding MXL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $128B AUM 35.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return

Bayesian Capital Management's MXL Position: Q1 2025 in Review

Bayesian Capital Management sold out of MaxLinear (MXL) in Q1 2025, closing a stake of 45,143 shares — an estimated $893K sold.

Bayesian Capital Management first reported a position in MXL in Q4 2015 and held it in 7 quarters. The position peaked at $893K in Q4 2024. 215 funds tracked by Wall St. Rank hold MXL as of Q1 2025.

Bayesian Capital Management reported no remaining MaxLinear position as of Q1 2025 after selling out during the quarter.
Bayesian Capital Management sold 45,143 MaxLinear shares in Q1 2025, an estimated $893K.
Bayesian Capital Management first reported a position in MaxLinear in Q4 2015 and held it in 7 quarters.
Bayesian Capital Management's MaxLinear position peaked at $893K in Q4 2024.
215 funds tracked by Wall St. Rank held MaxLinear as of Q1 2025.

Based on Bayesian Capital Management's 13F filing for Q1 2025, filed 15 May 2025.